Notably, neutralization of the increased serum levels of fibroblast growth factor 23 (FGF23), a regulator of phosphate homeostasis and bone mineralization and an inhibitor of erythropoiesis, restored bone microarchitecture and improved osteoid mineralization and anemia (61). Here, FGF23 is linked to anemia (phenotype).